Drug Profile
Research programme: antidepressants - Biovail Corporation
Alternative Names: BVF-045Latest Information Update: 22 Nov 2010
Price :
$50
*
At a glance
- Originator Biovail Corporation
- Developer Bausch Health Companies
- Class
- Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Major depressive disorder
Most Recent Events
- 24 Jul 2007 Preclinical trials in Depression in Canada (unspecified route)